XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,305,116 | +24.7% | 126,028 | +40.5% | 0.01% | -15.4% |
| Q2 2023 | $3,453,604 | -8.4% | 89,704 | -14.8% | 0.01% | -76.8% |
| Q1 2023 | $3,769,832 | +10.5% | 105,332 | +21.7% | 0.06% | -9.7% |
| Q4 2022 | $3,411,365 | +7.4% | 86,517 | -1.7% | 0.06% | +1.6% |
| Q3 2022 | $3,176,000 | -35.5% | 87,971 | -45.7% | 0.06% | -55.1% |
| Q2 2022 | $4,926,000 | +4.4% | 161,927 | +4.9% | 0.14% | +7.9% |
| Q1 2022 | $4,717,000 | +109.7% | 154,308 | +114.4% | 0.13% | +80.0% |
| Q4 2021 | $2,249,000 | +2126.7% | 71,984 | +841.3% | 0.07% | +48.9% |
| Q3 2018 | $101,000 | – | 7,647 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |